DCGI gives EUA to India’s first nasal vaccine against COVID-19
BBV154 is an intra-nasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BIRAC
BIRAC to grant Rs 600 million to Hester Biosciences
The grant is to support COVID vaccine manufacturing under Mission COVID Suraksha
Fibroheal raises debt funding from BIRAC
The company intends to scale up its go-to-market capabilities, recruit more people on board and create an impact through the…
COVID-19 vaccine from Biological E.,CORBEVAX gets EUA from DCGI for 12-18 age group
DCGI has already approved CORBEVAX for restricted use in emergency situation among adults
India and Colombia exchange views on cooperation in biotechnology sector and vaccine tie-up
A high-level delegation from Colombia led by Marta Lucia Ramirez de Rincón, Vice-President and Minister, Foreign Affairs, visited…
India’s first COVID-19 mRNA vaccine developed in partnership with DBT-BIRAC
The Vaccine Subject Expert Committee (SEC) reviewed the interim phase-I data and found that HGCO19 was safe, tolerable and…
Bharat Biotech’s intra-nasal COVID vaccine gets DCGI nod for phase-II and -III trials
Phase-I clinical trial has been completed in age groups ranging from 18 to 60 years
Facility augmentation of Bharat Biotech and three other PSEs being supported for augmented…
CDSCO puts in place system to fast track processing of application for clinical trial and approval for COVID-19 vaccines
Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58…
"As communicated by the manufacturers, the monthly vaccine production capacity of Covishield is projected to be increased from 110…
Zydus Cadila may apply for EUA of ZyCoV-D next week
If approved, it will be the world's first DNA vaccine against coronavirus and the fourth to become available in the country